Inventor

ZASK ARIE

US35 patents

⚠️ This page may combine multiple inventors who share the name “ZASK ARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZASK ARIE

WYETH CORP

Compounds for treating tumors

Compounds for treating tumors

Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors

Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors

Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors

Bicyclic antagonists selective for the αvβ3 integrin

Analogs of 17-hydroxywortmannin as PI3K inhibitors

Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors

Preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitors

AMERICAN CYANAMID CO

Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors

Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors

Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors

Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors

Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors

WYETH LLC

Triazine compounds as P13 kinase and MTOR inhibitors

Triazine compounds as PI3 kinase and mTOR inhibitors

Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof

Triazine compounds as PI3 kinase and mTOR inhibitors

Triazine compounds as PI3 kinase and MTOR inhibitors

Triazine compounds as PI3 kinase and mTOR inhibitors

AMERICAN HOME PROD

5-[(1- and 2-naphthalenyl)thio and sulfonyl]-2,4-thiazolidinediones and derivatives thereof

5-[(1- and 2-naphthalenyl) sulfonyl]-2,4-thiazolidinediones and derivatives thereof

5-(2-hydroxy-1-arylethylidene)- and 5-(2-oxo-1-arylethylidene)-2,4-thiazolidinediones and derivatives thereof

Heterocyclic bisphosphonic acid derivatives

VENKATESAN ARANAPAKAM MUDUMBAI

Triazine compounds as PI3 kinase and mTOR inhibitors

Triazine compounds as PI3 kinase and mTOR inhibitors

UNIV COLUMBIA

Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stress

NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic leukemia

PFIZER

Triazine compounds as PI3 kinase and mTOR inhibitors

ZASK ARIE

Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors

SHANGHAI INST MATERIA MEDICA CAS

Pyridopyrimidine or pyrimidopyrimidine compound, prepration method, pharmaceutical composition, and use thereof

CURRAN KEVIN JOSEPH

Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses